Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Fortis Healthcare Ltd. ( (IN:FORTIS) ) has provided an update.
Fortis Healthcare Limited has executed share purchase agreements to acquire significant stakes in its subsidiary, Agilus Diagnostics Limited. By acquiring shares from NYLIM Jacob Ballas India Fund III, LLC, Resurgence PE Investments Limited, and the International Finance Corporation, Fortis will increase its shareholding in Agilus to 89.2%, solidifying its control and potentially enhancing its market position in the diagnostics sector.
More about Fortis Healthcare Ltd.
Fortis Healthcare Limited operates in the healthcare industry, focusing on providing a range of medical services. The company’s primary market focus includes diagnostics services through its material subsidiary, Agilus Diagnostics Limited.
YTD Price Performance: -8.06%
Average Trading Volume: 49,806
Current Market Cap: 501B INR
For an in-depth examination of FORTIS stock, go to TipRanks’ Stock Analysis page.